Stay updated on Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page.

Latest updates to the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page
- Check2 days agoChange DetectedThis update reflects routine ClinicalTrials.gov record-history versioning, including a revision from v3.5.2 to v3.5.3 and indicating that the study record was revised around 2026-04-20/2026-04-23 for the “Study Design” and “Study Status” sections. It represents an additional submitted version of the same study record rather than a clearly substantive, user-critical change based on the provided diff.SummaryDifference0.2%

- Check9 days agoChange DetectedAdded a new Study Status entry on 2026-04-13 and updated the page revision to v3.5.2 (dated 2026-04-09). The previous revision v3.5.0 was removed on 2026-03-12.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedThe page revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check45 days agoChange DetectedA new version entry (2026-03-12) with Revision: v3.4.3 was added to the record history, and the previous version (2026-02-13) with Revision: v3.4.2 was deleted.SummaryDifference0.2%

- Check66 days agoChange DetectedOn 2026-02-13, Contacts/Locations and Study Status sections were added. On 2026-01-16, an entry was deleted.SummaryDifference0.2%

- Check73 days agoChange DetectedRevision: v3.4.2 replaced the previous v3.4.1 label in the page footer.SummaryDifference0.0%

Stay in the know with updates to Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page.